The German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC) conducted a comprehensive BRCA screening and revealed a higher mutation frequency in BRCA1 than that in BRCA2 [20]. This evidence concerns the gene BRCA2 and Hereditary breast and ovarian cancer syndrome.